My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 97

    1.

    Aggressive treatment of high-density lipoprotein cholesterol.

    Nicholls SJ.

    Ann Intern Med. 2005 Jun 21;142(12 Pt 1):1025; author reply 1025-6. No abstract available. PMID: 15968022 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Summaries for patients. Targeting cholesterol treatment toward increasing high-density lipoprotein levels.

    [No authors listed]

    Ann Intern Med. 2005 Jan 18;142(2):I46. No abstract available. PMID: 15657152 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol.

    Alsheikh-Ali AA, Lin JL, Abourjaily P, Ahearn D, Kuvin JT, Karas RH.

    Am J Cardiol. 2007 Nov 15;100(10):1499-501. Epub 2007 Sep 27.PMID: 17996508 [PubMed - indexed for MEDLINE]Related articles

    4.

    Is elevated high-density lipoprotein cholesterol always good for coronary heart disease?

    Sun Y, Yang Y, Pei W, Wu Y, Zhao J.

    Clin Cardiol. 2007 Nov;30(11):576-80.PMID: 18000966 [PubMed - indexed for MEDLINE]Related articles

    5.

    High-density lipoprotein cholesterol therapies: the next frontier in lipid management.

    Duffy D, Rader DJ.

    J Cardiopulm Rehabil. 2006 Jan-Feb;26(1):1-8. Review.PMID: 16617219 [PubMed - indexed for MEDLINE]Related articles

    6.

    Statin therapy alters the relationship between apolipoprotein B and low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol targets in high-risk patients: the MERCURY II (Measuring Effective Reductions in Cholesterol Using Rosuvastatin) trial.

    Ballantyne CM, Raichlen JS, Cain VA.

    J Am Coll Cardiol. 2008 Aug 19;52(8):626-32.PMID: 18702965 [PubMed - indexed for MEDLINE]Related articles

    7.

    Impaired antiatherogenic function of high-density lipoproteins in the presence of various risk factors for coronary heart disease.

    Serdyuk AP, Ozerova IN, Kamyshova TV, Perova NV, Metel'skaya VA.

    Bull Exp Biol Med. 2005 Mar;139(3):290-2. English, Russian. PMID: 16027833 [PubMed - indexed for MEDLINE]Related articles

    8.

    High-density lipoprotein cholesterol levels and cholesterol efflux: a missing link?

    Lorkowski S, Cullen P.

    Curr Opin Lipidol. 2004 Feb;15(1):81-4. No abstract available. PMID: 15166813 [PubMed - indexed for MEDLINE]Related articles

    9.

    High-density lipoprotein cholesterol: a potential therapeutic target for prevention of coronary artery disease.

    Chernobelsky A, Ashen MD, Blumenthal RS, Coplan NL.

    Prev Cardiol. 2007 Winter;10(1):26-30. Review.PMID: 17215630 [PubMed - indexed for MEDLINE]Related articles

    10.

    Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment.

    Kastelein JJ, van der Steeg WA, Holme I, Gaffney M, Cater NB, Barter P, Deedwania P, Olsson AG, Boekholdt SM, Demicco DA, Szarek M, LaRosa JC, Pedersen TR, Grundy SM; TNT Study Group; IDEAL Study Group.

    Circulation. 2008 Jun 10;117(23):3002-9. Epub 2008 Jun 2.PMID: 18519851 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    The independent correlation between high-density lipoprotein cholesterol and subsequent major adverse coronary events.

    Koro CE, Bowlin SJ, Stump TE, Sprecher DL, Tierney WM.

    Am Heart J. 2006 Mar;151(3):755.e1-755.e6.PMID: 16504648 [PubMed - indexed for MEDLINE]Related articles

    12.

    Impact of low high-density lipoproteins on in-hospital events and one-year clinical outcomes in patients with non-ST-elevation myocardial infarction acute coronary syndrome treated with drug-eluting stent implantation.

    Wolfram RM, Brewer HB, Xue Z, Satler LF, Pichard AD, Kent KM, Waksman R.

    Am J Cardiol. 2006 Sep 15;98(6):711-7. Epub 2006 Jul 17.PMID: 16950168 [PubMed - indexed for MEDLINE]Related articles

    13.

    Relation between on-treatment increments in serum high-density lipoprotein cholesterol levels and cardiac mortality in patients with coronary heart disease (from the Bezafibrate Infarction Prevention trial).

    Goldenberg I, Goldbourt U, Boyko V, Behar S, Reicher-Reiss H; BIP Study Group.

    Am J Cardiol. 2006 Feb 15;97(4):466-71. Epub 2005 Dec 22.PMID: 16461038 [PubMed - indexed for MEDLINE]Related articles

    14.

    [Prevalence of cardiovascular risk factors in coronary heart disease patients with different low-density lipoprotein phenotypes]

    Slapikas R, Luksiene D, Slapikiene B, Babarskiene MR, Grybauskiene R, Linoniene L.

    Medicina (Kaunas). 2005;41(11):925-31. Lithuanian. PMID: 16333215 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Niacin-ER/statin combination for the treatment of dyslipidemia: focus on low high-density lipoprotein cholesterol.

    Chrysant SG, Ibrahim M.

    J Clin Hypertens (Greenwich). 2006 Jul;8(7):493-9; quiz 500-1. Review.PMID: 16849903 [PubMed - indexed for MEDLINE]Related articles

    16.

    Low high-density lipoprotein cholesterol: an important consideration in coronary heart disease risk assessment.

    Majeed F, Miller M.

    Curr Opin Endocrinol Diabetes Obes. 2008 Apr;15(2):175-81. Review.PMID: 18316954 [PubMed - indexed for MEDLINE]Related articles

    17.

    HDL cholesterol: physiology, pathophysiology, and management.

    Link JJ, Rohatgi A, de Lemos JA.

    Curr Probl Cardiol. 2007 May;32(5):268-314. Review.PMID: 17481993 [PubMed - indexed for MEDLINE]Related articles

    18.

    The role of high-density lipoprotein cholesterol in the prevention and possible treatment of cardiovascular diseases.

    Choi BG, Vilahur G, Yadegar D, Viles-Gonzalez JF, Badimon JJ.

    Curr Mol Med. 2006 Aug;6(5):571-87. Review.PMID: 16918377 [PubMed - indexed for MEDLINE]Related articles

    19.

    Associations between high-density lipoprotein cholesterol and both stroke and coronary heart disease in the Asia Pacific region.

    Woodward M, Barzi F, Feigin V, Gu D, Huxley R, Nakamura K, Patel A, Ho S, Jamrozik K; Asia Pacific Cohort Studies Collaboration.

    Eur Heart J. 2007 Nov;28(21):2653-60. Epub 2007 Oct 11.PMID: 17933756 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Usefulness of the triglyceride-high-density lipoprotein versus the cholesterol-high-density lipoprotein ratio for predicting insulin resistance and cardiometabolic risk (from the Framingham Offspring Cohort).

    Kannel WB, Vasan RS, Keyes MJ, Sullivan LM, Robins SJ.

    Am J Cardiol. 2008 Feb 15;101(4):497-501.PMID: 18312765 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity